Continual Improvement of CDER BLA Submission, Assessment, and Facility Readiness/Inspection | Sada Siva Rao.M, (M.Sc, RAC-Drugs).
Continual Improvement of CDER BLA Submission, Assessment, and Facility Readiness/Inspection | Sada Siva Rao.M, (M.Sc, RAC-Drugs).
4.8K views5 months ago
linkedin.com
Sangamo Therapeutics initiates rolling submission of BLA to U.S. FDA
Sangamo Therapeutics initiates rolling submission of BLA to U.S. FDA
5 months ago
marketscreener.com
Electronic Submission of Adverse Event Reports to FDA FAERS
Electronic Submission of Adverse Event Reports to FDA FAERS
Apr 28, 2019
fda.gov
Xbrane Plans to Resubmit BLA to FDA in March--Expects Six-Month Review Process
Xbrane Plans to Resubmit BLA to FDA in March--Expects Six-Month Review Process
6 months ago
marketscreener.com
FDA Guidance on Manufacturing Site Change Supplements: Submission Type Determination
FDA Guidance on Manufacturing Site Change Supplements: Submission Type Determination
Jul 6, 2022
regdesk.co
Preparing Your Pre-Submission with the Content FDA Wants to See
Preparing Your Pre-Submission with the Content FDA Wants to See
Jun 23, 2021
greenlight.guru
510k Electronic Submission Guidance for FDA 510k Submissions
510k Electronic Submission Guidance for FDA 510k Submissions
Oct 2, 2023
medicaldeviceacademy.com
6:28
IND, NDA, and BLA Explained: Key Regulatory Submissions in Drug Development | Everblink Health Care
2 views2 months ago
YouTubeEverblink Healthcare Pvt Ltd
0:15
We have initiated a rolling Biologics License Application (BLA) submission to the @FDA to seek approval for our lead candidate as a potential one-time treatment for hereditary angioedema (#HAE). Read the press release here: https://t.co/js8lE5nlb8
1.4K views3 weeks ago
x.comIntellia Therapeutics
1:15:25
Establishment Registration– DRLS Workshop 2020
6.9K viewsNov 10, 2020
YouTubeU.S. Food and Drug Administration
49:43
U.S. FDA Drug Labeling Requirements
11.1K viewsJun 26, 2019
YouTubeRegistrar Corp
46:23
Electronic Common Technical Document (eCTD)
14K viewsJul 29, 2021
YouTubeU.S. Food and Drug Administration
5:20
Data Requirements for Biosimilars
29.1K viewsMay 22, 2018
YouTubeU.S. Food and Drug Administration
48:21
FDA Adverse Event Reporting System (FAERS) Overview - Pharmacovigilance 2020
10K viewsJun 15, 2020
YouTubeU.S. Food and Drug Administration
55:59
Submitting IND Safety Reports to FDA Adverse Event Reporting System (FAERS)- Nov. 1, 2019
10.9K viewsJan 17, 2020
YouTubeU.S. Food and Drug Administration
1:00:47
Understanding New Drug Applications (NDAs)
30.3K viewsAug 17, 2018
YouTubeRho
54:27
How to Prepare & Conduct Pre-Submission Meetings
2.6K viewsJul 13, 2020
YouTubeGreenlight Guru
8:58:15
FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track
8.5K viewsJul 22, 2021
YouTubeU.S. Food and Drug Administration
38:21
NDA and BLA Application Review Process (6of15) REdI Annual Conference – May 29-30, 2019
17.1K viewsMar 27, 2020
YouTubeU.S. Food and Drug Administration
2:16
Breaking Down the FDA Pre-Submission Process - An Essential Guide
1.1K viewsApr 18, 2019
YouTubeMedTech Crossroads
2:02
5 Things You Need to Know About the Drug Approval Process
95K viewsDec 5, 2016
YouTubeU.S. Food and Drug Administration
46:00
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
25.2K viewsAug 6, 2020
YouTubeU.S. Food and Drug Administration
29:03
Drug Master File (DMF) Submissions on New FDA Form 3938
10.5K viewsJan 8, 2021
YouTubeU.S. Food and Drug Administration
34:37
Lifecycle Changes to Chemistry, Manufacture, and Controls in NDAs - REdI 2020
4.4K viewsAug 31, 2020
YouTubeU.S. Food and Drug Administration
3:25
How to Register an Investigational New Drug (IND) to the US FDA
3K viewsJul 16, 2020
YouTubeGlobal Regulatory Partners Inc.
46:45
Premarket Approval (PMA) Agreement with FDA for the Medical Device Companies
4.2K viewsJun 23, 2016
YouTubeGlobalCompliance Panel
40:53
Submit Your Investigational New Drug (IND) Application and Clinical Holds (9/14) REdI 2017
6.8K viewsAug 6, 2020
YouTubeU.S. Food and Drug Administration
54:28
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
18.9K viewsAug 6, 2020
YouTubeU.S. Food and Drug Administration
28:11
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
15K viewsAug 31, 2020
YouTubeU.S. Food and Drug Administration
27:10
Overview of Post-approval Chemistry, Manufacture, and Controls (CMC) Changes to an NDA - REdI 2020
10.3K viewsAug 31, 2020
YouTubeU.S. Food and Drug Administration
See more
Static thumbnail place holder